Buprenorphine dosing choices in specific populations: review of expert opinion-Reference-Cited by-同舟云学术

Buprenorphine dosing choices in specific populations: review of expert opinion

Published:2016-08-02 Issue:13 Volume:17 Page:1727-1731
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Maremmani Icro¹,Rolland Benjamin²,Somaini Lorenzo³,Roncero Carlos⁴,Reimer Jens⁵,Wright Nat⁶,Littlewood Richard⁷,Krajci Peter⁸,Alho Hannu⁹,D’Agnone Oscar¹⁰,Simon Nicolas¹¹¹²¹³

Affiliation:

1. Department of Neurosciences, Santa Chiara University Hospital, University of Pisa, Pisa, Italy

2. Departments of Addiction Medicine and Pharmacology, INSERM, University Hospital of Lille, Lille, France

3. Addiction Treatment Centre, Biella, Italy

4. Addiction and Dual Diagnosis Unit, Department of Psychiatry, Vall d’Hebron Hospital, Barcelona, Spain

5. Director at Centre for Interdisciplinary Addiction Research, University Medical Centre Hamburg-Eppendorf, Martini Strasse, Germany

6. Spectrum Community Health CIC, Wakefield, UK

7. Applied Strategic, London, UK

8. Division of Mental Health and Addiction, Department of Substance Use Disorder Treatment, Oslo University Hospital, Oslo, Norway

9. HA, Clinicum, University of Helsinki and University Hospital, Helsinki, Finland

10. Faculty of Medical and Human Sciences, Institute of Brain Behaviour and Mental Health, University of Manchester, Manchester, UK

11. Service de Pharmacologie Clinique, Sainte Marguerite Hospital, Marseille, France

12. Department of Clinical Pharmacology, Medical School of Marseilles, Marseille, France

13. Aix Marseille University, INSERM, UMR 912 IRD, SESSTIM, Marseille, France

Funder

Indivior UK, Ltd

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2016.1209486

Reference36 articles.

1. Treating Drug Abuse and Addiction in the Criminal Justice System

2. Bell J. Medications in recovery: re-orientating drug dependence treatment Appendix C – opioid substitution treatment and its effectiveness: review of the evidence. National Treatment Agency for Substance Misuse. 2012 Jul 1–13.

3. Suboxone® (Buprenorphine/Naloxone) as an Agonist Opioid Treatment in Spain: A Budgetary Impact Analysis

4. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful administration of extended-release buprenorphine in the emergency department;The American Journal of Emergency Medicine;2024-10

2. Substance use disorders in schizophrenia: Prevalence, etiology, biomarkers, and treatment;Personalized Medicine in Psychiatry;2023-07

3. Multicenter Observational/Exploratory Study Addressed to the Evaluation of the Effectiveness and Safety of Pharmacological Therapy in Opioid-Dependent Patients in Maintenance Therapy in Southern Italy;Pharmaceutics;2022-02-21

4. Factors That Affect Patient Attrition in Buprenorphine Treatment for Opioid Use Disorder: A Retrospective Real-World Study Using Electronic Health Records;Neuropsychiatric Disease and Treatment;2021-10

5. Prolonged-release buprenorphine formulations: Perspectives for clinical practice;Therapies;2020-09